Summary &horbar; Leukaemia inhibitory factor (LIF), a pleiotropic cytokine, is implicated in blastocyst implantation in mice and maintains the development of ovine embryos in culture. Previously, LIF mRNA and protein were demonstrated in the endometrium throughout the oestrous cycle and early pregnancy in the ewe. In this study pregnant ewes were passively immunised against human recombinant LIF with polyclonal antibodies raised in cows by active immunisation. Ewes were immunised during two stages of early pregnancy: blastocyst development to hatching, and blastocyst elongation to implantation. Only animals passively immunised against LIF showed detectable LIF antibodies in their sera and in uterine lumina flushings by radioimmunoassay and Western blot analysis. Pregnancy was confirmed by ultrasound on day 55 and a 33.5% non-significant decrease in pregnancy rate of anti-LIF treated animals was observed, when compared to animals in control groups (untreated or treated with bovine anti-keyhole limpet hemocyanin). Cows actively immunised with recombinant human LIF and exhibiting high levels of LIF antibodies in their sera at the time of blastocyst implantation also showed a reduced pregnancy rate in comparison to control animals. Although LIF may not be obligatory for implantation in ruminants it does appear to have a role during the establishment of pregnancy.
LIF / immunisation / early pregnancy / implantation Résumé &horbar; Effet de l'immunisation contre le LIF sur l'établissement de la gestation chez la brebis et la vache. Le rôle du LIF dans l'implantation chez la souris et dans le développement du blas-
INTRODUCTION
Leukaemia inhibitory factor (LIF) is a pleiotropic cytokine that acts on many different cells (Hilton 1992; Metcalf 1992) . When mouse blastocysts were cultured in the presence of LIF they had a greater mass of trophectodenn in comparison to control blastocysts (Robertson et al, 1991) and LIF significantly increased the number of embryos hatching and exhibiting trophoblast outgrowth (Lavranos et al, 1995) . Furthermore, recombinant human LIF improved the development of ovine embryos in culture (Fry et al, 1992) indicating that LIF may be one of many factors involved in improving embryo viability during sustained in vitro culture.
In the mouse uterus, LIF is expressed in the endometrial glands coincident with the time of blastocyst implantation (Bhatt et al, 1991) and mice that lack a functional LIF gene have normal blastocysts that fail to implant (Stewart et al, 1992) . Furthermore, the low affinity LIF receptor (LIFR) is an integral component of the functional LIF receptor complex and interacts with gp 130 to form a high affinity receptor (Ip et al, 1992; Taga and Kishimoto, 1992; Gearing et al, 1992; Davis et al, 1993) . Disruption of LIFR leads to perinatal death as mice homozygous for the mutation die shortly after or during birth (Ware et al, 1995) , while embryos homozygous for the gp 130 mutation die between 12.5 days postcoitum and term (Yoshida et al, 1996) . In both cases normal implantation of embryos occurs, suggesting that endometrial LIF may not act directly through LIFR or gp130 on the blastocyst. Since both mutations are lethal their effects in adult mice cannot be investigated.
In human endometrium, LIF mRNA is present transiently with the highest expression observed during the mid and late secretory phases of the menstrual cycle (Charnock-Jones et al, 1994; Kojima et al, 1994; Arici et al, 1995; Vogiagis et al, 1996a; Cullinan et al, 1996) . Immunoreactive LIF has been localised in the endometrial epithelium and stroma throughout the menstrual cycle (Vogiagis et al, 1996a) (Vogiagis et al, 1996b) , although these are not confined to the time of blastocyst implantation as in the mouse (Bhatt et al, 1991) .
The sheep, unlike the human and mouse, has a characteristically long intrauterine blastocyst development before implantation (Bindon, 1971) . Whereas in the mouse the blastocyst hatches from the zona pellucida and implants on the uterine wall on the fourth day of pregnancy (Finn and McLaren, 1967; Orsini and McLaren, 1967) , in the sheep hatching and implantation occur about eight days apart (Bindon, 1971; Rowson and Moor, 1976 (fig 3a, b) showed the highest anti-LIF titres 6 days after the tertiary injection, on day 16 (fig 3a) and day 22 (fig 3b) , respectively. By day 22 (fig 3a) and day 35 (fig 3b) Parr and Parr ( 1986) demonstrated that IgG in mouse serum is taken up by uterine luminal and glandular epithelial cells (Wang et al, 1989) . Furthermore, serum proteins selectively enter the uterine lumen. Sheep uterine flushings contain a large number of serum proteins, which include IgG (Salamonsen et al, 1984 (Hilton, 1992; Metcalf, 1992 (Ip et al, 1992; Taga and Kishimoto, 1992; Gearing et al, 1992; Davis et al, 1993 
